Inventurus Knowledge Solutions IPO

Inventurus Knowledge Solutions IPO

Listed

MainboardOpens 12 December 2024Closes 16 December 2024

Founded in 2006, Inventurus Knowledge Solutions Limited (IKS Health) is a leading health technology company dedicated to reducing administrative burdens in healthcare. IKS Health provides end-to-end services, including…

Show more
Price band
₹1265 - ₹1329
Issue size
₹2497.92 Cr
Lot size
11 shares
Type
Mainboard
GMP
₹421 (+31.7%)
Est. listing
₹1,750
Est. profit / app
₹4,631
Retail quota
—

Key ratios

As per RHP / filings
Face value
₹1
EPS
24.31
P/E ratio
54.66
RoNW
32%
ROE
32%
Debt / Equity
-0.06
Advertisement

Timeline

  1. IPO Opens

    12 Dec 2024

  2. IPO Closes

    16 Dec 2024

  3. Allotment

    17 Dec 2024

  4. Listing

    19 Dec 2024

IPO Timeline & Listing Details

EventDate
IPO Open Date12 December 2024
IPO Close Date16 December 2024
Allotment Date17 December 2024
Listing Date19 December 2024

Investment Categories

CategoryLotsAmount
Retail (Min)
1₹14,619
Retail (Max)Just less than ₹2,00,000
13₹1,90,047
SHNI (Min)Just above ₹2,00,000
14₹2,04,666
SHNI (Max)Below ₹10,00,000
68₹9,94,092
BHNIAbove ₹10,00,000
69₹10,08,711

IPO Objectives

  • The company will not receive any proceeds from the Offer and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.

Strengths

  • The company offers a wide range of services across outpatient and inpatient care, serving patients, physicians, nurses, and healthcare organizations.
  • It has shown strong financial performance, with solid revenue growth and improving margins over the past three years.
  • The business is not capital intensive, with profitability driven by a scalable, asset-light model and cost-efficient strategies.

Weaknesses

  • The company has had past FEMA compliance issues and has filed compounding applications with the RBI, which are still pending. This may lead to regulatory actions or penalties.
  • Failure to comply with healthcare laws and regulations could result in financial penalties, operational changes, or damage to the company’s reputation.
  • The company’s revenue mainly comes from U.S.-based healthcare organizations, exposing it to risks from sector and geographic concentration.
Advertisement

Financial Performance

Period Ended30 Sep 202431 Mar 202431 Mar 202331 Mar 2022
Assets (₹ Cr.)2,790.523,027.52988.31787.52
Revenue (₹ Cr.)1,294.611,857.941,060.16784.47
PAT (₹ Cr.)208.58370.49305.23232.97
Net Worth (₹ Cr.)1,377.111,157.86828.64647.07

Peer Comparison

CompanyP/B RatioP/E RatioRONW (%)Net Worth (₹ Cr.)

Subscription Details

No daily bids available.

No subscription statistics available.

Advertisement

Company Details

  • Inventurus Knowledge Solutions Limited
  • Building No. 5 & 6, Unit No. 801, 8th Floor, Mindspace SEZ, Thane Belapur Road, Airoli, Navi Mumbai, Thane, 400708
  • +91 22 3964 3205
  • company.secretary@ikshealth.com
  • https://ikshealth.com/

Registrar Details

Frequently Asked Questions

See live numbers on GMP, Subscription, and Allotment pages.

Inventurus Knowledge Solutions IPO News & Updates

Follow the latest updates for Inventurus Knowledge Solutions IPO, including grey market moves and allotment news.

Inventurus Knowledge Solutions IPO IPO Pages

Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.

Sources

We match Inventurus Knowledge Solutions IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.

  • SEBIRules for IPO allotment and disclosures in India
  • NSEExchange notices, bidding data, and listing updates
  • BSEExchange notices and IPO allotment check tools
  • RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
  • Link Intime India Private LtdOfficial site to check allotment status for this IPO

Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.

Reviewed by

Dinesh Agrawal · Lead IPO Analyst

15+ years in Indian markets and IPO research. He reviews IPO dates and key details before they go live.

Loading comments...